These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2834967)

  • 41. cAMP and extrarenal vasopressin V2 receptors in dogs.
    Liard JF
    Am J Physiol; 1992 Dec; 263(6 Pt 2):H1888-91. PubMed ID: 1336316
    [TBL] [Abstract][Full Text] [Related]  

  • 42. L-histidine augments the response to 1-deamino-8-D-arginine vasopressin in Brattleboro homozygous (di/di) rats.
    Charnogursky G; Moses AM; Coulson R; Bernstein M; Carvounis CP
    J Clin Invest; 1990 Mar; 85(3):921-8. PubMed ID: 2155931
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vasopressin as a possible contributor to hypertension.
    Yazaki Y; Ohuchi Y; Ashida T; Tsai R; Yoshizumi M
    Jpn Circ J; 1984 Feb; 48(2):188-95. PubMed ID: 6321816
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of vasopressin on sodium transport across inner medullary collecting duct.
    Kudo LH; van Baak AA; Rocha AS
    Am J Physiol; 1990 May; 258(5 Pt 2):F1438-47. PubMed ID: 2159725
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Central vasopressin receptors are upregulated by deoxycorticosterone acetate.
    Swords BH; Wyss JM; Berecek KH
    Brain Res; 1991 Sep; 559(1):10-6. PubMed ID: 1838296
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Blunted pressor responsiveness to quinpirole, a specific dopamine D2 receptor agonist, in conscious deoxycorticosterone acetate/NaCl hypertensive rats is related to atrial natriuretic peptide release.
    Chen YF; Jin HK; Paul R; Nagahama S
    J Pharmacol Exp Ther; 1988 Aug; 246(2):485-92. PubMed ID: 2969976
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased urinary excretion of PGE2 during inappropriate antidiuresis induced by DDAVP.
    Craven PA; Verbalis JG; DeRubertis FR
    Kidney Int; 1986 Jun; 29(6):1110-5. PubMed ID: 3462422
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extrarenal Na+ balance, volume, and blood pressure homeostasis in intact and ovariectomized deoxycorticosterone-acetate salt rats.
    Titze J; Luft FC; Bauer K; Dietsch P; Lang R; Veelken R; Wagner H; Eckardt KU; Hilgers KF
    Hypertension; 2006 Jun; 47(6):1101-7. PubMed ID: 16636196
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epinephrine and dDAVP administration in patients with congenital nephrogenic diabetes insipidus. Evidence for a pre-cyclic AMP V2 receptor defective mechanism.
    Bichet DG; Razi M; Arthus MF; Lonergan M; Tittley P; Smiley RK; Rock G; Hirsch DJ
    Kidney Int; 1989 Nov; 36(5):859-66. PubMed ID: 2559238
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kinetics of active sodium transport in aortas from control and deoxycorticosterone hypertensive rats.
    Jones AW
    Hypertension; 1981; 3(6):631-40. PubMed ID: 7298118
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Collecting duct-specific knockout of the endothelin A receptor alters renal vasopressin responsiveness, but not sodium excretion or blood pressure.
    Ge Y; Stricklett PK; Hughes AK; Yanagisawa M; Kohan DE
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F692-8. PubMed ID: 15928212
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vasopressin V2 receptors, ENaC, and sodium reabsorption: a risk factor for hypertension?
    Bankir L; Bichet DG; Bouby N
    Am J Physiol Renal Physiol; 2010 Nov; 299(5):F917-28. PubMed ID: 20826569
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of AV3V lesions on development of DOCA-salt hypertension and vascular Na+-pump activity.
    Songu-Mize E; Bealer SL; Caldwell RW
    Hypertension; 1982; 4(5):575-80. PubMed ID: 6286476
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lack of increase in concentrations of cerebrospinal fluid sodium in rats with various stages of DOCA-salt hypertension.
    Takata Y; Yamashita Y; Takishita S; Fujishima M
    Life Sci; 1988; 42(12):1223-9. PubMed ID: 3347147
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vasopressin inhibits diuresis induced by water immersion in humans.
    Farrow S; Banta G; Schallhorn S; May R; Mers A; Cadaret L; Rydstedt L; Lockette W
    J Appl Physiol (1985); 1992 Sep; 73(3):932-6. PubMed ID: 1400058
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of water deprivation, desmopressin (DDAVP) infusion, and oral loads of water, Na+ and NH4+ on urinary excretion of epidermal growth factor in the rat.
    Jørgensen PE; Poulsen SS; Nexø E; Christensen S
    Regul Pept; 1993 Mar; 44(1):17-24. PubMed ID: 8484016
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Short-term stimulation of the thiazide-sensitive Na+-Cl- cotransporter by vasopressin involves phosphorylation and membrane translocation.
    Mutig K; Saritas T; Uchida S; Kahl T; Borowski T; Paliege A; Böhlick A; Bleich M; Shan Q; Bachmann S
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F502-9. PubMed ID: 20007345
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Altered regulation of renal sodium transporters and natriuretic peptide system in DOCA-salt hypertensive rats.
    Bae EH; Kim IJ; Ma SK; Kim SW
    Regul Pept; 2009 Oct; 157(1-3):76-83. PubMed ID: 19422859
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of Selective Agonists of V1a, V2, and V1b Receptors on Sodium Transport in Rat Kidney.
    Golosova DV; Karavashkina TA; Kutina AV; Marina AS; Natochin YV
    Bull Exp Biol Med; 2016 Apr; 160(6):751-4. PubMed ID: 27165083
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vasopressin V1a and V2 receptor mRNA in deoxycorticosterone acetate-salt hypertension in the rat.
    Risvanis J; Johnston CI; Phillips PA; Burrell LM
    Clin Sci (Lond); 1998 May; 94(5):517-23. PubMed ID: 9682675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.